-
H.C. Wainwright Reiterates Buy Rating on BioLife Solutions (BLFS)
-
BioLife Solutions (BLFS) Tops Q3 EPS by 2c ; Offers Guidance
-
BioLife Solutions sells cold chain logistics unit for $25.5 million
-
KeyBanc on BioLife Solutions (BLFS): 'NDR Reveals Multiple Avenues to Reach LT Growth'
-
KeyBanc: 'Cell & Gene Therapy Getting More Support; BLFS, CYRX, TKNO With the Most Exposure'
-
KeyBanc: 'Cell & Gene Therapy Getting More Support; BLFS, CYRX, TKNO With the Most Exposure'
-
BioLife Solutions (BLFS) PT Raised to $32 at H.C. Wainwright
-
BioLife Solutions (BLFS) Misses Q2 EPS by 30c ; Offers Guidance
-
H.C. Wainwright Reiterates Buy Rating on BioLife Solutions (BLFS)
-
BioLife Solutions (BLFS) Tops Q1 EPS by 4c ; Offers Guidance
-
BioLife Solutions (BLFS) Defended at Craig Hallum
-
KeyBanc on BioLife Solutions (BLFS): 'Bullish Outlook for BLFS with Sexton Portfolio'
-
BioLife Solutions (BLFS) PT Raised to $30 at H.C. Wainwright
-
Benchmark Reiterates Buy Rating on BioLife Solutions (BLFS)
-
BioLife Solutions (BLFS) Tops Q4 EPS by 4c ; Offers Guidance
-
BioLife Solutions (BLFS) PT Raised to $34 at Maxim Group
-
KeyBanc Reiterates Overweight Rating on BioLife Solutions (BLFS) Following Tony Hunt's Appointment
-
Benchmark Reiterates Buy Rating on BioLife Solutions (BLFS)
-
BioLife Solutions (BLFS) PT Raised to $33 at KeyBanc, Citing 'Tantalizing Growth Potential of +25%'
-
BioLife Solutions (BLFS) PT Lowered to $27 at H.C. Wainwright
-
Stephens Reiterates Overweight Rating on BioLife Solutions (BLFS)
-
BioLife Solutions (BLFS) Announces $6.1M Sale of its Custom Biogenic Systems Freezer Subsidiary
-
BioLife Solutions (BLFS) PT Raised to $31 at TD Cowen
-
BioLife Solutions (BLFS) Tops Q3 EPS by 4c, Beats on Revenue; Offers FY24 Revenue Guidance
-
BioLife Solutions (BLFS) Sells SciSafe Biostorage for $73M Cash
-
H.C. Wainwright Starts BioLife Solutions (BLFS) at Buy
-
BioLife Solutions (BLFS) Misses Q2 EPS by 36c, provides guidance

